Literature DB >> 9094991

Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease.

P L Jones1, K N Cowan, M Rabinovitch.   

Abstract

Progressive pulmonary hypertension is characterized by smooth muscle cell proliferation and migration leading to occlusive arterial lesions. Previously, using cultured smooth muscle cells, we demonstrated that epidermal growth factor (EGF)-dependent proliferation and migration are dependent on tenascin-C (Tn) and cellular fibronectin (Fn), respectively. In this study we applied immunohistochemistry to lung biopsy tissue from patients with congenital heart defects and pulmonary hypertension to determine how the distribution and intensity of Tn, EGF, proliferating cell nuclear antigen (PCNA), and Fn expression related to arterial abnormalities. With mildly increased wall thickness, minimal Tn, PCNA, and EGF was evident. With progressive hypertrophy, moderately intense foci of Tn were apparent in the adventitia, periendothelium, and occasionally the media but not consistently co-distributing with EGF and PCNA. With obstructive lesions, intense neointimal Tn expression co-localized with EGF and PCNA. Fn accumulation in the periendothelium increased with medial hypertrophy and became more widespread in a diffuse pattern with neointimal formation. The neointima was predominantly composed of alpha-smooth-muscle-actin-positive cells, occasional inflammatory cells with no evidence of apoptosis. These studies are consistent with Tn modulating EGF-dependent neointimal smooth muscle cell proliferation and Fn providing a gradient for smooth muscle cell migration from media to neointima.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094991      PMCID: PMC1858188     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis.

Authors:  R Chiquet-Ehrismann; E J Mackie; C A Pearson; T Sakakura
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

2.  Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization.

Authors:  I W Prosser; K R Stenmark; M Suthar; E C Crouch; R P Mecham; W C Parks
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

3.  Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration.

Authors:  N Boudreau; E Turley; M Rabinovitch
Journal:  Dev Biol       Date:  1991-02       Impact factor: 3.582

4.  Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle.

Authors:  N Boudreau; Z Werb; M J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease.

Authors:  M Rabinovitch; S G Haworth; A R Castaneda; A S Nadas; L M Reid
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

6.  Developmentally regulated changes in extracellular matrix in endothelial and smooth muscle cells in the ductus arteriosus may be related to intimal proliferation.

Authors:  N Boudreau; M Rabinovitch
Journal:  Lab Invest       Date:  1991-02       Impact factor: 5.662

7.  Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study.

Authors:  L Todorovich-Hunter; D J Johnson; P Ranger; F W Keeley; M Rabinovitch
Journal:  Lab Invest       Date:  1988-02       Impact factor: 5.662

Review 8.  Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions.

Authors:  P Ekblom; E Aufderheide
Journal:  Int J Dev Biol       Date:  1989-03       Impact factor: 2.203

9.  Induction of tenascin in healing wounds.

Authors:  E J Mackie; W Halfter; D Liverani
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

10.  Hexabrachion proteins in embryonic chicken tissues and human tumors.

Authors:  H P Erickson; H C Taylor
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

View more
  63 in total

Review 1.  Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension.

Authors:  M Rabinovitch
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

2.  Suppression subtractive hybridization identifies distinctive expression markers for coronary and internal mammary arteries.

Authors:  Minghui Qin; Zhaohui Zeng; Jie Zheng; Prediman K Shah; Stephen M Schwartz; Lawrence D Adams; Behrooz G Sharifi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

Review 3.  Targeting non-malignant disorders with tyrosine kinase inhibitors.

Authors:  Friedrich Grimminger; Ralph T Schermuly; Hossein A Ghofrani
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

4.  Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia.

Authors:  T Minamino; H Christou; C M Hsieh; Y Liu; V Dhawan; N G Abraham; M A Perrella; S A Mitsialis; S Kourembanas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

5.  Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease.

Authors:  Wanli Ma; Weihong Han; Peter A Greer; Rubin M Tuder; Haroldo A Toque; Kevin K W Wang; R William Caldwell; Yunchao Su
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 6.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

7.  Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis.

Authors:  B Jian; P L Jones; Q Li; E R Mohler; F J Schoen; R J Levy
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 8.  Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

Authors:  K C Penumatsa; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-27       Impact factor: 5.464

9.  Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  Shuxin Liang; Ankit A Desai; Stephen M Black; Haiyang Tang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.

Authors:  Revathi Rajkumar; Kazuhisa Konishi; Thomas J Richards; David C Ishizawar; Andrew C Wiechert; Naftali Kaminski; Ferhaan Ahmad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.